Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
Go back to Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.22 +0.59 (12.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.63 | 52 Week High | $45.34 | |||
| Open | $4.63 | 52 Week Low | $15.92 | |||
| Day High | $5.25 | P/E | 2.24 | |||
| Day Low | $4.63 | EPS | $2.33 | |||
| Volume | 1,924,378 | |||||
